Of note, matching our data from treatment-naïve tumor tissues, all of these three circulating PBMC subpopulations showed higher frequencies in PBMCs of L-TTF2 patients (Table S10) prior to the start of second-line therapy. Here, TTF2 is linked to neoplasm.